Saltar al contenido
Merck

Dppa2/4 Facilitate Epigenetic Remodeling during Reprogramming to Pluripotency.

Cell stem cell (2018-08-28)
Charles Hernandez, Zheng Wang, Bulat Ramazanov, Yin Tang, Sameet Mehta, Cheryl Dambrot, Yu-Wei Lee, Kaleab Tessema, Ishan Kumar, Michael Astudillo, Thomas A Neubert, Shangqin Guo, Natalia B Ivanova
RESUMEN

As somatic cells are converted into induced pluripotent stem cells (iPSCs), their chromatin is remodeled to a pluripotent configuration with unique euchromatin-to-heterochromatin ratios, DNA methylation patterns, and enhancer and promoter status. The molecular machinery underlying this process is largely unknown. Here, we show that embryonic stem cell (ESC)-specific factors Dppa2 and Dppa4 play a key role in resetting the epigenome to a pluripotent state. They are induced in reprogramming intermediates, function as a heterodimer, and are required for efficient reprogramming of mouse and human cells. When co-expressed with Oct4, Klf4, Sox2, and Myc (OKSM) factors, Dppa2/4 yield reprogramming efficiencies that exceed 80% and accelerate reprogramming kinetics, generating iPSCs in 2 to 4 days. When bound to chromatin, Dppa2/4 initiate global chromatin decompaction via the DNA damage response pathway and contribute to downregulation of somatic genes and activation of ESC enhancers, all of which enables an efficient transition to pluripotency. Our work provides critical insights into how the epigenome is remodeled during acquisition of pluripotency.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
ANTI-FLAG® M2 monoclonal antibody produced in mouse, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Sigma-Aldrich
Anti-α-tubulina monoclonal antibody produced in mouse, clone B-5-1-2, purified from hybridoma cell culture
Roche
KAPA Express Extract, with PCR ReadyMix